These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35397747)

  • 61. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells.
    Orlandi A; Pucci S; Ciucci A; Pichiorri F; Ferlosio A; Spagnoli LG
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):348-53. PubMed ID: 15591223
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
    Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
    Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen.
    Blumenstein B; Saad F; Hotte S; Chi KN; Eigl B; Gleave M; Jacobs C
    Cancer Med; 2013 Aug; 2(4):468-77. PubMed ID: 24156019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.
    Ma L; Tian X; Wang F; Zhang Z; Du C; Xie X; Kornmann M; Yang Y
    Cancer Biol Ther; 2016 Oct; 17(10):1051-1061. PubMed ID: 27573434
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage.
    Tarquini C; Pucci S; Scioli MG; Doldo E; Agostinelli S; D'Amico F; Bielli A; Ferlosio A; Caredda E; Tarantino U; Orlandi A
    Aging (Albany NY); 2020 Jun; 12(11):10129-10146. PubMed ID: 32516132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
    Chen X; Bui KC; Barat S; Thi Nguyen ML; Bozko P; Sipos B; Kalesse M; Malek NP; Plentz RR
    Cancer Lett; 2017 Jul; 399():20-28. PubMed ID: 28408354
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
    Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
    J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
    Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
    PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.
    Chou TY; Chen WC; Lee AC; Hung SM; Shih NY; Chen MY
    Cell Signal; 2009 May; 21(5):704-11. PubMed ID: 19166932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
    Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
    BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
    Satoh M; Takano S; Sogawa K; Noda K; Yoshitomi H; Ishibashi M; Mogushi K; Takizawa H; Otsuka M; Shimizu H; Miyazaki M; Nomura F
    Cancer Sci; 2017 Apr; 108(4):795-803. PubMed ID: 28161904
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
    Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
    Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.
    Lourda M; Trougakos IP; Gonos ES
    Int J Cancer; 2007 Feb; 120(3):611-22. PubMed ID: 17096323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clusterin/Apolipoprotein J up-regulation after zinc exposure, replicative senescence or differentiation of human haematopoietic cells.
    Trougakos IP; Pawelec G; Tzavelas C; Ntouroupi T; Gonos ES
    Biogerontology; 2006; 7(5-6):375-82. PubMed ID: 16955214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
    Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
    Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.